ECSP14024082A - Material no viable derivado de probióticos para la prevención y tratamiento de infecciones - Google Patents

Material no viable derivado de probióticos para la prevención y tratamiento de infecciones

Info

Publication number
ECSP14024082A
ECSP14024082A ECIEPI201424082A ECPI201424082A ECSP14024082A EC SP14024082 A ECSP14024082 A EC SP14024082A EC IEPI201424082 A ECIEPI201424082 A EC IEPI201424082A EC PI201424082 A ECPI201424082 A EC PI201424082A EC SP14024082 A ECSP14024082 A EC SP14024082A
Authority
EC
Ecuador
Prior art keywords
probiotics
infections
prevention
treatment
material derived
Prior art date
Application number
ECIEPI201424082A
Other languages
English (en)
Inventor
Eduard Poels
Karin Overkamp
Machtelt Braaksma
Gabriele Gross
Tol Eric Van
Original Assignee
Zaner Bloser Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48045112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP14024082(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zaner Bloser Inc filed Critical Zaner Bloser Inc
Publication of ECSP14024082A publication Critical patent/ECSP14024082A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Una composición que comprende un sobrenadante de cultivo a partir de una fase de crecimiento exponencial tardía de un proceso de cultivo por lotes para un probiótico tal como el LGG, para uso en el tratamiento o prevención de una infección por un patógeno tal como el C. sakazakii.
ECIEPI201424082A 2012-03-23 2014-10-23 Material no viable derivado de probióticos para la prevención y tratamiento de infecciones ECSP14024082A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12161083 2012-03-23
PCT/US2013/032757 WO2013142403A1 (en) 2012-03-23 2013-03-18 Probiotic derived non-viable material for infection prevention and treatment

Publications (1)

Publication Number Publication Date
ECSP14024082A true ECSP14024082A (es) 2015-09-30

Family

ID=48045112

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201424082A ECSP14024082A (es) 2012-03-23 2014-10-23 Material no viable derivado de probióticos para la prevención y tratamiento de infecciones

Country Status (18)

Country Link
US (2) US20130251829A1 (es)
EP (1) EP2827725A1 (es)
CN (2) CN108714157A (es)
AR (1) AR090473A1 (es)
AU (1) AU2013235365B2 (es)
CA (1) CA2868109A1 (es)
CO (1) CO7151477A2 (es)
EC (1) ECSP14024082A (es)
HK (1) HK1204869A1 (es)
MX (1) MX360591B (es)
MY (1) MY169754A (es)
NZ (1) NZ627915A (es)
PE (1) PE20142276A1 (es)
PH (1) PH12014502112A1 (es)
RU (1) RU2014137188A (es)
SG (1) SG11201404378XA (es)
TW (1) TWI587864B (es)
WO (1) WO2013142403A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
US20150157048A1 (en) 2013-12-11 2015-06-11 Mead Johnson Nutrition Company Nutritional compositions containing stearidonic acid and uses thereof
US20150290261A1 (en) * 2014-04-10 2015-10-15 Mead Johnson Nutrition Company Methods of use for probiotics and prebiotics
US20150305385A1 (en) 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US20160029682A1 (en) 2014-08-01 2016-02-04 Mead Johnson Nutrition Company Hydrolyzed lactose-containing nutritional compositions and uses thereof
US20160095339A1 (en) 2014-10-01 2016-04-07 Mead Johnson Nutrition Company Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
US20180064739A1 (en) 2016-09-06 2018-03-08 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180103675A1 (en) 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
US20180160714A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180161292A1 (en) 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US10980269B2 (en) 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same
US20180161381A1 (en) * 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions and methods for reducing the occurrence or severity of viral infections, bacterial infections and viral and bacterial co-infections
US20180168215A1 (en) 2016-12-21 2018-06-21 Mead Johnson Nutrition Company Nutritional compositions containing inositol and uses thereof
US20180332881A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
US20180333426A1 (en) 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
CN107812018A (zh) * 2017-11-13 2018-03-20 浙江禾健生营养食品有限公司 一种灭活益生菌制品、制备方法及其应用
US20190208807A1 (en) 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
GB2573538B (en) 2018-05-09 2023-01-04 Mjn Us Holdings Llc Pediatric nutritional compositions and methods for infants delivered by C-section

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
NZ241359A (en) 1991-01-24 1994-08-26 Martek Corp Supplementation of infant formula by the addition of at least two different polyunsaturated fatty acids obtained from at least two different microbial sources; compositions comprising such oils
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
CN1164186C (zh) * 2001-04-29 2004-09-01 上海光明乳业股份有限公司 益菌奶及其制造方法
EP1384483A1 (en) 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
US7407652B2 (en) * 2005-06-03 2008-08-05 Aquatechnics Inc. Probiotic system for aquaculture
JP2009516738A (ja) * 2005-11-21 2009-04-23 ティーガスク−ザ アグリカルチャー アンド フード デベロップメント オーソリティー カゼイン由来の抗菌ペプチドおよびそれを生成するＬａｃｔｏｂａｃｉｌｌｕｓ株
RU2468807C2 (ru) * 2007-02-28 2012-12-10 Мед Джонсон Нутришен Компани Детское питание, содержащее инактивированный пробиотик
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis
RU2350648C1 (ru) * 2007-09-14 2009-03-27 Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны РФ Российской академии сельскохозяйственных наук Способ оценки антагонистической активности пробиотиков на основе лиофилизированной биомассы анаэробных бактерий по отношению к патогенным микобактериям
EP2130440A1 (en) 2008-06-06 2009-12-09 N.V. Nutricia Inhibiting E. sakazakii growth
US8137718B2 (en) * 2008-09-19 2012-03-20 Mead Johnson Nutrition Company Probiotic infant products
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
US20130251829A1 (en) * 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
CN104531562B (zh) * 2014-12-09 2018-09-14 北京农学院 一种植物乳杆菌植物亚种及其抗单增李斯特菌细菌素的制备方法

Also Published As

Publication number Publication date
MY169754A (en) 2019-05-15
PH12014502112A1 (en) 2014-12-10
EP2827725A1 (en) 2015-01-28
CO7151477A2 (es) 2014-12-29
TWI587864B (zh) 2017-06-21
AR090473A1 (es) 2014-11-12
AU2013235365B2 (en) 2016-05-19
AU2013235365A1 (en) 2014-08-21
CN104219968A (zh) 2014-12-17
HK1204869A1 (en) 2015-12-11
CA2868109A1 (en) 2013-09-26
US20130251829A1 (en) 2013-09-26
RU2014137188A (ru) 2016-05-20
NZ627915A (en) 2016-07-29
CN108714157A (zh) 2018-10-30
MX360591B (es) 2018-11-09
MX2014010150A (es) 2014-09-16
PE20142276A1 (es) 2015-01-23
SG11201404378XA (en) 2014-08-28
WO2013142403A1 (en) 2013-09-26
TW201400124A (zh) 2014-01-01
US20170157185A1 (en) 2017-06-08

Similar Documents

Publication Publication Date Title
ECSP14024082A (es) Material no viable derivado de probióticos para la prevención y tratamiento de infecciones
MX2017005252A (es) Metodos para la preparacion de ribosidos.
MX2017008720A (es) Derivados y metodos para tratamiento de las infecciones por hepatitis b.
MY188541A (en) Besifloxacin for the treatment of resistant acne
PH12016501379A1 (en) Azepane derivatives and methods of treating hepatitis b infections
EP3505620A4 (en) 2D ORGANOID FOR INFECTIONS AND GROWTH OF HUMAN DIARRHOEVIRUS AND USE OF THE TWO-DIMENSIONAL ORGANOID
MX2018006116A (es) Materiales y metodos para el tratamiento de miopatias basadas en titina y otras titinopatias.
EP3912652C0 (en) BACTERIAL NANOFIBRILLARY CELLULOSE BIO INK FOR THREE-DIMENSIONAL BIOPRINTING FOR CELL CULTIVATION, TISSUE GROWING AND REGENERATIVE MEDICINE APPLICATIONS
UY34201A (es) Compuestos de azaindol y métodos para el tratamiento de vih.
MD4589B1 (ro) Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C
EA030204B8 (ru) Производные изоиндолина для применения в лечении вирусной инфекции
EP3205713A4 (en) Method for culturing 1,4-dioxane-decomposing bacteria, culture medium, and 1,4-dioxane treatment method using 1,4-dioxane-decomposing bacteria
EP2588121A4 (en) C5A ANALOGUES AND METHODS OF USE THEREOF
MX2016009248A (es) Compuestos que contienen nitrogeno y su uso como agentes antibacterianos.
TW201613953A (en) Process for the preparation of cyclic depsipeptides
MX2016005750A (es) Acidos nucleicos y metodos para detectar microorganismos patogenos y beneficos.
MX2015008486A (es) Composiciones y metodos para tratar infecciones bacterianas.
WO2016100615A3 (en) Methods and composition for neutralization of influenza
IN2014MU00916A (es)
EP4226936A3 (en) Non-neuroinvasive viruses and uses thereof
WO2013067160A3 (en) Anti-bacterial polypeptides and pathogen specific synthetic antibodies
IN2013MU03216A (es)
MX2016014628A (es) Metodo para expandir las celulas madre adultas de sangre entera.
HUE038826T2 (hu) Berendezés fertõzõ, különösen orvosi hulladék kezelésére
CO6831974A2 (es) Usos, métodos y composiciones biológicas del genero paecilomyces para el control, prevención y erradicación de fitoparásitos en cultivos de solanáceas